Aisha opens her laptop at 7:45 a.m.
Aisha Krishnamurthy is a fictional operator. All submission counts, dollar figures, IPO valuation differentials, and team sizes are illustrative scenarios. See Important Notice on Examples and Numbers.
Aisha Krishnamurthy is the Director of Regulatory Affairs at a top-twenty biopharma. The CEO needs three INDs and one NDA in twenty-four months.
Her Researcher has pulled FDA guidance, comparator regulatory history, prior submissions, and advisory committee transcripts, then surfaced the stability data needed for a pending CMC response.
Her Producer has drafted IND sections, CMC summaries, and a response letter. Her Coordinator has scheduled cross-functional review, pre-submission prep, legal review, and medical monitor input.
By 9:08 a.m. Aisha has done what used to be Tuesday and most of Wednesday.